Meta-analysis of Natural Killer Cell Cytotoxicity in Myalgic Encephalomyelitis/chronic Fatigue Syndrome

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2024 Nov 1

PMID 39483457

Authors

James N Baraniuk

Natalie Eaton-Fitch

Sonya Marshall-Gradisnik

Affiliations

Soon will be listed here.

Abstract

Systematic Review Registration: https://www.crd.york.ac.uk/prospero/, identifier CRD42024542140.

References

Robertson M, Schacterle R, Mackin G, Wilson S, Bloomingdale K, Ritz J . Lymphocyte subset differences in patients with chronic fatigue syndrome, multiple sclerosis and major depression. Clin Exp Immunol. 2005; 141(2):326-32. PMC: 1809442. DOI: 10.1111/j.1365-2249.2005.02833.x. View

Huth T, Brenu E, Ramos S, Nguyen T, Broadley S, Staines D . Pilot Study of Natural Killer Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis. Scand J Immunol. 2015; 83(1):44-51. DOI: 10.1111/sji.12388. View

Mawle A, Nisenbaum R, Dobbins J, Gary Jr H, Stewart J, Reyes M . Immune responses associated with chronic fatigue syndrome: a case-control study. J Infect Dis. 1997; 175(1):136-41. DOI: 10.1093/infdis/175.1.136. View

Brenu E, Hardcastle S, Atkinson G, van Driel M, Kreijkamp-Kaspers S, Ashton K . Natural killer cells in patients with severe chronic fatigue syndrome. Auto Immun Highlights. 2015; 4(3):69-80. PMC: 4389023. DOI: 10.1007/s13317-013-0051-x. View

Rivas J, Palencia T, Fernandez G, Garcia M . Association of T and NK Cell Phenotype With the Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Front Immunol. 2018; 9:1028. PMC: 5954087. DOI: 10.3389/fimmu.2018.01028. View

Brenu E, Van Driel M, Staines D, Ashton K, Hardcastle S, Keane J . Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis. J Transl Med. 2012; 10:88. PMC: 3464733. DOI: 10.1186/1479-5876-10-88. View

Evans D, Folds J, Petitto J, Golden R, Pedersen C, Corrigan M . Circulating natural killer cell phenotypes in men and women with major depression. Relation to cytotoxic activity and severity of depression. Arch Gen Psychiatry. 1992; 49(5):388-95. DOI: 10.1001/archpsyc.1992.01820050052009. View

Subedi N, Van Eyndhoven L, Hokke A, Houben L, van Turnhout M, Bouten C . An automated real-time microfluidic platform to probe single NK cell heterogeneity and cytotoxicity on-chip. Sci Rep. 2021; 11(1):17084. PMC: 8385055. DOI: 10.1038/s41598-021-96609-9. View

Ablashi D, Eastman H, Owen C, Roman M, Friedman J, Zabriskie J . Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J Clin Virol. 2000; 16(3):179-91. DOI: 10.1016/s1386-6532(99)00079-7. View

10.

See D, Cimoch P, Chou S, Chang J, TILLES J . The in vitro immunomodulatory effects of glyconutrients on peripheral blood mononuclear cells of patients with chronic fatigue syndrome. Integr Physiol Behav Sci. 1998; 33(3):280-7. DOI: 10.1007/BF02688668. View

11.

Caligiuri M, Murray C, Buchwald D, Levine H, Cheney P, Peterson D . Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J Immunol. 1987; 139(10):3306-13. View

12.

Gleser L, Olkin I . Models for estimating the number of unpublished studies. Stat Med. 1996; 15(23):2493-507. DOI: 10.1002/(SICI)1097-0258(19961215)15:23<2493::AID-SIM381>3.0.CO;2-C. View

13.

Shi J, Luo D, Weng H, Zeng X, Lin L, Chu H . Optimally estimating the sample standard deviation from the five-number summary. Res Synth Methods. 2020; 11(5):641-654. DOI: 10.1002/jrsm.1429. View

14.

Rasmussen A, Nielsen H, Andersen V, Barington T, Bendtzen K, Hansen M . Chronic fatigue syndrome--a controlled cross sectional study. J Rheumatol. 1994; 21(8):1527-31. View

15.

Vanherberghen B, Olofsson P, Forslund E, Sternberg-Simon M, Khorshidi M, Pacouret S . Classification of human natural killer cells based on migration behavior and cytotoxic response. Blood. 2013; 121(8):1326-34. DOI: 10.1182/blood-2012-06-439851. View

16.

Carruthers B . Definitions and aetiology of myalgic encephalomyelitis: how the Canadian consensus clinical definition of myalgic encephalomyelitis works. J Clin Pathol. 2006; 60(2):117-9. PMC: 1860613. DOI: 10.1136/jcp.2006.042754. View

17.

Brenu E, Van Driel M, Staines D, Ashton K, Ramos S, Keane J . Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. J Transl Med. 2011; 9:81. PMC: 3120691. DOI: 10.1186/1479-5876-9-81. View

18.

Nguyen T, Johnston S, Clarke L, Smith P, Staines D, Marshall-Gradisnik S . Impaired calcium mobilization in natural killer cells from chronic fatigue syndrome/myalgic encephalomyelitis patients is associated with transient receptor potential melastatin 3 ion channels. Clin Exp Immunol. 2016; 187(2):284-293. PMC: 5217865. DOI: 10.1111/cei.12882. View

19.

Michelet X, Dyck L, Hogan A, Loftus R, Duquette D, Wei K . Metabolic reprogramming of natural killer cells in obesity limits antitumor responses. Nat Immunol. 2018; 19(12):1330-1340. DOI: 10.1038/s41590-018-0251-7. View

20.

Yang C, Siebert J, Burns R, Gerbec Z, Bonacci B, Rymaszewski A . Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptome. Nat Commun. 2019; 10(1):3931. PMC: 6718415. DOI: 10.1038/s41467-019-11947-7. View